Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02927340 |
|---|---|
| Brief Title: | A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions |
| First Submitted : | September 26, 2016 |
| First Submitted that Met QC Criteria : | October 5, 2016 |
| First Posted : | October 7, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 7, 2021 |
| Last Update Posted : | March 9, 2021 |